Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users
HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users
Status: Enrolling
Updated:  8/21/2017
Jacques Initiative
mi
from
Baltimore, MD
HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users
HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users
Status: Enrolling
Updated: 8/21/2017
Jacques Initiative
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pith Moromo 2: Cohort to Study Health Consequences of Food and Nutrition Insecurity During Pregnancy and Lactation
Status: Enrolling
Updated:  8/23/2017
Northwestern University
mi
from
Evanston, IL
Pith Moromo 2: Cohort to Study Health Consequences of Food and Nutrition Insecurity During Pregnancy and Lactation
Status: Enrolling
Updated: 8/23/2017
Northwestern University
mi
from
Evanston, IL
Click here to add this to my saved trials
Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation
Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation
Status: Enrolling
Updated:  8/24/2017
CUNY
mi
from
New York, NY
Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation
Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation
Status: Enrolling
Updated: 8/24/2017
CUNY
mi
from
New York, NY
Click here to add this to my saved trials
Targeting Platelets in Chronic HIV Infection
Targeting Platelets in Chronic HIV Infection
Status: Enrolling
Updated:  8/28/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Targeting Platelets in Chronic HIV Infection
Targeting Platelets in Chronic HIV Infection
Status: Enrolling
Updated: 8/28/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
A Phase 1 Clinical Trial to Evaluate the Initiation of Treatment Versus no Treatment During Acute HIV-1 Infection
Status: Enrolling
Updated:  8/30/2017
Massachusetts General Hospital
mi
from
Boston, MA
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
A Phase 1 Clinical Trial to Evaluate the Initiation of Treatment Versus no Treatment During Acute HIV-1 Infection
Status: Enrolling
Updated: 8/30/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
Status: Enrolling
Updated:  9/1/2017
Rockefeller University
mi
from
New York, NY
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
Status: Enrolling
Updated: 9/1/2017
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated:  9/7/2017
Drexel University College of Medicine
mi
from
Philadelphia, PA
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated: 9/7/2017
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated:  9/7/2017
Victoria Hospital
mi
from
Bangalore,
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated: 9/7/2017
Victoria Hospital
mi
from
Bangalore,
Click here to add this to my saved trials
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Status: Enrolling
Updated:  9/12/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Status: Enrolling
Updated: 9/12/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Status: Enrolling
Updated:  9/12/2017
Duke University
mi
from
Durham, NC
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Status: Enrolling
Updated: 9/12/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Drug-drug Interaction (DDI) Rifabutin
Pharmacokinetic Interaction Study to Evaluate the Pharmacokinetic Effect of Rifabutin on BMS-626529, the Active Moiety of BMS-663068, With and Without Ritonavir in Healthy Subjects
Status: Enrolling
Updated:  9/21/2017
GSK Investigational Site
mi
from
Austin, TX
Drug-drug Interaction (DDI) Rifabutin
Pharmacokinetic Interaction Study to Evaluate the Pharmacokinetic Effect of Rifabutin on BMS-626529, the Active Moiety of BMS-663068, With and Without Ritonavir in Healthy Subjects
Status: Enrolling
Updated: 9/21/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
GSK1349572 Drug Interaction Study With Efavirenz
A Phase 1, Open Label, Single Sequence, Three Period Study to Evaluate the Single Dose Pharmacokinetics of GSK1349572 100mg Versus 50mg and the Effect of Efavirenz 600mg Once Daily on the Pharmacokinetics, Safety and Tolerability of GSK1349572 50mg Once Daily in Healthy Adult Subjects (ING114005)
Status: Enrolling
Updated:  9/21/2017
GSK Investigational Site
mi
from
Buffalo, NY
GSK1349572 Drug Interaction Study With Efavirenz
A Phase 1, Open Label, Single Sequence, Three Period Study to Evaluate the Single Dose Pharmacokinetics of GSK1349572 100mg Versus 50mg and the Effect of Efavirenz 600mg Once Daily on the Pharmacokinetics, Safety and Tolerability of GSK1349572 50mg Once Daily in Healthy Adult Subjects (ING114005)
Status: Enrolling
Updated: 9/21/2017
GSK Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
Status: Enrolling
Updated:  9/22/2017
Pacific Institute for Research and Evaluation
mi
from
Chapel Hill, NC
School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
Status: Enrolling
Updated: 9/22/2017
Pacific Institute for Research and Evaluation
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
Status: Enrolling
Updated:  9/22/2017
Moi University, Department of Nursing Sciences
mi
from
Eldoret,
School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
Status: Enrolling
Updated: 9/22/2017
Moi University, Department of Nursing Sciences
mi
from
Eldoret,
Click here to add this to my saved trials
A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring
A Multicenter, Open-label, Randomized, Two-period, Crossover Non-inferiority Trial to Assess the Functionality of Female Condoms With a Silicone Elastomer Vaginal Ring
Status: Enrolling
Updated:  9/26/2017
California Family Health Council
mi
from
Los Angeles, CA
A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring
A Multicenter, Open-label, Randomized, Two-period, Crossover Non-inferiority Trial to Assess the Functionality of Female Condoms With a Silicone Elastomer Vaginal Ring
Status: Enrolling
Updated: 9/26/2017
California Family Health Council
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
City of Hope National Medical Center
mi
from
Duarte, CA
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
University of California, San Diego Medical Center
mi
from
La Jolla, CA
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
University of California, San Diego Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
BMT Program at Northside Hospital
mi
from
Atlanta, GA
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
BMT Program at Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
Johns Hopkins Medical Institution
mi
from
Baltimore, MD
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
Johns Hopkins Medical Institution
mi
from
Baltimore, MD
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
University of Maryland Medical Systems, Greenebaum Cancer Center
mi
from
Baltimore, MD
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
University of Maryland Medical Systems, Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
University of Rochester
mi
from
Rochester, NY
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
University of Florida College of Medicine
mi
from
Gainesville, FL
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
Emory University
mi
from
Atlanta, GA
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
Weill-Cornell Medical College
mi
from
New York, NY
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
UCLA
mi
from
Los Angeles, CA
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
University of CA, SF
mi
from
San Francisco, CA
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
University of CA, SF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated:  9/27/2017
Washington University/ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
Autologous Transplant in HIV Patients (BMT CTN 0803)
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Status: Enrolling
Updated: 9/27/2017
Washington University/ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Effects of Growth Hormone Releasing Hormone in HIV
Effects of Growth Hormone Releasing Hormone on Fat Redistribution, Cardiovascular Indices, and Growth Hormone Secretion in HIV Lipodystrophy
Status: Enrolling
Updated:  9/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Growth Hormone Releasing Hormone in HIV
Effects of Growth Hormone Releasing Hormone on Fat Redistribution, Cardiovascular Indices, and Growth Hormone Secretion in HIV Lipodystrophy
Status: Enrolling
Updated: 9/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Contextualizing & Responding to HIV Risk Behaviors
Contextualizing & Responding to HIV Risk Behaviors Among Black Drug Offenders
Status: Enrolling
Updated:  9/29/2017
Columbia University Medical Center
mi
from
New York, NY
Contextualizing & Responding to HIV Risk Behaviors
Contextualizing & Responding to HIV Risk Behaviors Among Black Drug Offenders
Status: Enrolling
Updated: 9/29/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients
HIV and Asthma in the Post-ART (Antiretroviral Therapy) Era
Status: Enrolling
Updated:  10/2/2017
Duke Asthma, Allergy and Airway Center
mi
from
Durham, NC
Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients
HIV and Asthma in the Post-ART (Antiretroviral Therapy) Era
Status: Enrolling
Updated: 10/2/2017
Duke Asthma, Allergy and Airway Center
mi
from
Durham, NC
Click here to add this to my saved trials
VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption
An Exploratory, Open-Label Study of VRC-HIVMAB060-00-AB (VRC01) in Subjects With Chronic HIV Infection Undergoing Analytical Treatment Interruption
Status: Enrolling
Updated:  10/2/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption
An Exploratory, Open-Label Study of VRC-HIVMAB060-00-AB (VRC01) in Subjects With Chronic HIV Infection Undergoing Analytical Treatment Interruption
Status: Enrolling
Updated: 10/2/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)
HIV Expression in Patients With Viral Loads Suppressed on HAART
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)
HIV Expression in Patients With Viral Loads Suppressed on HAART
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Leukapheresis for Research on HCV-Coinfected Patients
Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications
Status: Enrolling
Updated:  10/5/2017
Family and Medical Counseling Service
mi
from
Washington, D.C.,
Leukapheresis for Research on HCV-Coinfected Patients
Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications
Status: Enrolling
Updated: 10/5/2017
Family and Medical Counseling Service
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Leukapheresis for Research on HCV-Coinfected Patients
Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications
Status: Enrolling
Updated:  10/5/2017
Unity Health Care/Walker Jones
mi
from
Washington, D.C.,
Leukapheresis for Research on HCV-Coinfected Patients
Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications
Status: Enrolling
Updated: 10/5/2017
Unity Health Care/Walker Jones
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Leukapheresis for Research on HCV-Coinfected Patients
Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications
Status: Enrolling
Updated:  10/5/2017
Whitman Walker Clinic
mi
from
Washington, D.C.,
Leukapheresis for Research on HCV-Coinfected Patients
Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications
Status: Enrolling
Updated: 10/5/2017
Whitman Walker Clinic
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Leukapheresis for Research on HCV-Coinfected Patients
Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Leukapheresis for Research on HCV-Coinfected Patients
Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States
Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States
Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients With HIV/AIDS
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients With HIV/AIDS
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples
Status: Enrolling
Updated:  10/5/2017
Missouri Center for Reproductive Medicine & Fertility
mi
from
Columbia, MO
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples
Status: Enrolling
Updated: 10/5/2017
Missouri Center for Reproductive Medicine & Fertility
mi
from
Columbia, MO
Click here to add this to my saved trials
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated:  10/6/2017
UCLA CARE Ctr
mi
from
Los Angeles, CA
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated: 10/6/2017
UCLA CARE Ctr
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated:  10/6/2017
Quest Clinical Research
mi
from
San Francisco, CA
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated: 10/6/2017
Quest Clinical Research
mi
from
San Francisco, CA
Click here to add this to my saved trials
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated:  10/6/2017
Circle CARE Center, LLC
mi
from
Norwalk, CT
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated: 10/6/2017
Circle CARE Center, LLC
mi
from
Norwalk, CT
Click here to add this to my saved trials
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated:  10/6/2017
Orlando Immunology Center
mi
from
Orlando, FL
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated: 10/6/2017
Orlando Immunology Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated:  10/6/2017
Southwest CARE Center
mi
from
Santa Fe, NM
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated: 10/6/2017
Southwest CARE Center
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated:  10/6/2017
Ricky K. Hsu, Md, Pc
mi
from
New York, NY
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated: 10/6/2017
Ricky K. Hsu, Md, Pc
mi
from
New York, NY
Click here to add this to my saved trials
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated:  10/6/2017
Central Texas Clinical Research
mi
from
Austin, TX
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Status: Enrolling
Updated: 10/6/2017
Central Texas Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials